Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinol binding protein 7 is an intracellular carrier protein primarily expressed in endothelial cells of small blood vessels, as well as kidney, heart, and colon tissues. It belongs to the CRBP family, is encoded by the *RBP7* gene on human chromosome 1, and transports retinol and fatty acids within cells to help regulate vitamin A metabolism and stability. RBP7 serves both as a direct target gene and a cofactor of PPARγ in vascular endothelium, essential for protection against oxidative stress and endothelial dysfunction during cardiovascular challenges such as obesity and angiotensin II exposure. It binds several retinol isomers (all-trans-, 13-cis-, and 9-cis-retinol) and plays a role in a PPARγ/RBP7/adiponectin transcriptional pathway critical for vessel health. While it does not currently have direct drug modulators in clinical use, its regulatory role makes it a candidate therapeutic target for cardiovascular and metabolic disease intervention.
Drugs that activate PPARγ (such as rosiglitazone) upregulate RBP7, which mediates antioxidant and protective responses in endothelial cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinol binding protein 7 (RBP7).